These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2695884)

  • 21. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 22. Intratympanic corticotherapy and tinnitus control after sudden hearing loss.
    Barreto MA; Silva IB; de Oliveira CA; Bahmad F
    Int Tinnitus J; 2012; 17(2):186-93. PubMed ID: 24333893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New pharmacological and clinical properties of the venoactive agent: Venoruton (Paroven). Studies presented at the 1st Mediterranean Congress of Angiology. Corfu, Greece, May 29 to June 3, 1988. Abstracts.
    Int Angiol; 1988; 7(4 Suppl):1-16. PubMed ID: 3249081
    [No Abstract]   [Full Text] [Related]  

  • 24. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M; Bodzenta A
    Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract]   [Full Text] [Related]  

  • 26. [The results of sudden deafness treatment].
    Zientalska E; Moszyński B; Kapiszewska D; Czarnocka E; Kownacka E
    Otolaryngol Pol; 1998; 52(6):707-12. PubMed ID: 10064991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
    Becker HM; Niedermaier G; Orend KH
    Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influencing of xerostomia and asialia during psychotropic drug therapy with benzopyrone].
    Beck-Steiner G
    MMW Munch Med Wochenschr; 1979 Apr; 121(16):569-70. PubMed ID: 111051
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etiology and pathogenesis of sudden deafness].
    Friedrich G
    Laryngol Rhinol Otol (Stuttg); 1985 Feb; 64(2):62-6. PubMed ID: 3982177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acute superficial thrombosis and follow-up by computerized thermography.
    Belcaro G; Errichi BM; Laurora G; Cesarone MR; Candiani C
    Vasa; 1989; 18(3):227-34. PubMed ID: 2678804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
    Juon M; Messelhäuser I
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
    [No Abstract]   [Full Text] [Related]  

  • 32. [Spontaneous remission in sudden deafness].
    Weinaug P
    HNO; 1984 Aug; 32(8):346-51. PubMed ID: 6480433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot?
    Frank K; Ding G; Raue F; Ziegler R
    Dev Ophthalmol; 1989; 20():127-9. PubMed ID: 2687048
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report].
    Böhme D
    ZFA (Stuttgart); 1980 May; 56(13):953-9. PubMed ID: 7415464
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K; Oliva I; Prerovský I; Linhart J
    Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of sudden deafness: our experience].
    Hellín Meseguer D; Merino Gálvez E; Mondéjar JM; Escobar Sánchez C; García Ortega F; Rosique Arias M
    Acta Otorrinolaringol Esp; 1990; 41(3):165-7. PubMed ID: 2124495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
    Shukla VK; Sethi AK; Garg SK; Ganguly NK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1989; 299():127-33. PubMed ID: 2774763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.